(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Paul Wahlgren, Managing Director of Skyler Brand Ventures, on luxury skin care and their patended neuropeptide technology used in a new concentrate for the face: XEP-30.

Anthropic Finalizing $15 Billion Pre-IPO Credit Facility
23:29

Broadcom Slides After AI Chip Forecast Underwhelms Investors
20:57

Chevron to Invest $7 Billion to Double Its Venezuelan Output
23:39